Hair follicle is a target of stress hormone and autoimmune reactions

Journal of Dermatological Science

Volumn 60, Issue 2, 2010, Pages 67-73

  Ito, Taisuke ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alopecia areata; CRH; Hair follicle; HPA axis; Immune privilege; MHC class

Indexed keywords

ALPHA INTERMEDIN; BETA ENDORPHIN; CORTICOTROPIN; STRESS HORMONE; TRANSFORMING GROWTH FACTOR BETA;

ALOPECIA AREATA; AUTOIMMUNITY; ENDOCRINE SYSTEM; ENVIRONMENTAL STRESS; HAIR FOLLICLE; HAIR GROWTH; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOBIOLOGY; MAST CELL; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ALOPECIA AREATA; AUTOIMMUNITY; CORTICOTROPIN-RELEASING HORMONE; HAIR FOLLICLE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; STRESS, PSYCHOLOGICAL;

EID: 77958504055     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2010.09.006     Document Type: Review

References (85)

1. Messenger A.G. The control of hair growth and pigmentation. Disorders of hair growth: diagnosis and treatment 2003, 49-74. McGraw-Hill, New York. 2nd ed. E.A. Olsen (Ed.).
2. Paus R., Nickoloff B.J., Ito T. A 'hairy' privilege. Trends Immunol 2005, 26:32-40.
3. Ito T., Meyer K.C., Ito N., Paus R. Immune privilege and the skin. Curr Dir Autoimmun 2008, 10:27-52.
4. Ito N., Ito T., Kromminga A., Bettermann A., Takigawa M., Kees F., et al. Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB J 2005, 19:1332-1334.
5. Ito N., Ito T., Bettermann A., Paus R. The human hair bulb is a source and target of CRH. J Invest Dermatol 2004, 122:235-237.
6. Billingham R.E. Transplantation immunity evoked by skin allografts and expressed in intact skin. Immunology of the, skin. (Adv Biol Skin vol. XI) 1971, 183-198. Appleton-Century-Crofts, New York. W. Montagna, R.E. Billingham (Eds.).
7. Billingham R.E., Silvers W.K. A biologist's reflections on dermatology. J Invest Dermatol 1971, 57:227-240.
8. Billingham R.E. The immunobiology of tissue transplantation. Int Dent J 1971, 21:478-487.
9. Gilhar A., Landau M., Assy B., Shalaginov R., Serafimovich S., Kalish R.S. Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice. J Invest Dermatol 2001, 117:1357-1362.
10. Gilhar A., Kalish R.S. Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev 2006, 5:64-69.
11. Paus R., Stenn K.S., Link R.E. Telogen skin contains an inhibitor of hair growth. Br J Dermatol 1990, 122:777-778.
12. Hofmann U., Tokura Y., Rückert R., Paus R. The anagen hair cycle induces systemic immunosuppression of contact hypersensitivity in mice. Cell Immunol 1998, 184:65-73.
13. Tokura Y., Hofmann U., RöverMüller-Röver S., Paus R., Wakita H., Yagi H., et al. Spontaneous hair follicle cycling may influence the development of murine contact photosensitivity by modulating keratinocyte cytokine production. Cell Immunol 1997, 178:172-179.
14. Hoffman U., Tokura Y., Nishijima T., Takigawa M., Paus R. Hair cycle-dependent changes in skin immune functions: anagen-associated depression of sensitization for contact hypersensitivity in mice. J Invest Dermatol 1996, 106:598-604.
15. Hoffmann R., Happle R., Paus R. Elements of the interleukin-1 signaling system show hair cycle-dependent gene expression in murine skin. Eur J Dermatol 1998, 8:475-477.
16. Paus R., Slominski A., Czarnetzki B.M. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb?. Yale J Biol Med 1993, 66:541-554.
17. Slominski A., Paus R., Mazurkiewicz J. Proopiomelanocortin expression in the skin during induced hair growth in mice. Experientia 1992, 48:50-54.
18. Slominski A., Wortsman J., Mazurkiewicz J.E., Matsuoka L., Dietrich J., Lawrence K., et al. Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med 1993, 122:658-666.
19. Paus R., Botchkarev V.A., Botchkareva N.V., Mecklenburg L., Luger T., Slominski A. The skin POMC system (SPS): leads and lessons from the hair follicle. Ann N Y Acad Sci 1999, 885:350-363.
20. Slominski A., Botchkareva N.V., Botchkarev V.A., Chakraborty A., Luger T., Uenalan M., et al. Hair cycle-dependent production of ACTH in mouse skin. Biochim Biophys Acta 1998, 1448:147-152.
21. Cerwenka A., Swain S.L. GF-beta1: immunosuppressant and viability factor for T lymphocyte. Microb Infect 1999, 1:1291-1296.
22. Foitzik K., Lindner G., Müller-Röver S., Maurer M., Botchkareva N., Botchkarev V., et al. Control of murine hair follicle regression (catagen) by TGF-b1 in vivo. FASEB J 2000, 14:752-760.
23. Paus R., Ito N., Takigawa M., Ito T. The hair follicle and immune privilege. J Investig Dermatol Symp Proc 2003, 8:188-194.
24. Boehm T. Quality control in self/nonself discrimination. Cell 2006, 125:845-858.
25. Yokoyama W.M., Kim S. Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol Rev 2006, 214:143-154.
26. Gasser S., Raulet D.H. Activation and self-tolerance of natural killer cells. Immunol Rev 2006, 214:130-142.
27. Bryceson Y.T., March M.E., Ljunggren H.G., Long E.O. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev 2006, 214:73-91.
28. Johansson M.H., Hoglund P. The dynamics of natural killer cell tolerance. Semin Cancer Biol 2006, 16:393-403.
29. Andoniou C.E., Andrews D.M., Degli-Esposti M.A. Natural killer cells in viral infection: more than just killers. Immunol Rev 2006, 214:239-250.
30. Borrego F., Masilamani M., Marusina A.I., Tang X., Coligan J.E. The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance. Immunol Res 2006, 35:263-278.
31. Khakoo S.I., Carrington M. KIR and disease: a model system or system of models?. Immunol Rev 2006, 214:186-201.
32. Christoph T., Müller-Rover S., Audring H., Tobin D.J., Hermes B., Cotsarelis G., et al. The human hair immune system: cellular composition and immune privilege. Br J Dermatol 2000, 142:862-873.
33. Long E.O. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 1999, 17:875-904.
34. Vivier E., Daeron M. Immunoreceptor tyrosine-based inhibition motifs. Immunol Today 1997, 18:286-291.
35. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999, 285:727-729.
36. Wu J., Song Y., Bakker A.B., Bauer S., Spies T., Lanier L.L., et al. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 1999, 285:730-732.
37. Middleton D., Curran M., Maxwell L. Natural killer cells and their receptors. Transpl Immunol 2002, 10:147-164.
38. Carosella E.D., Rouas-Freiss N., Paul P., Dausset J. HLA-G a tolerance molecule from the major histocompatibility complex. Immunol Today 1999, 20:60-62.
39. Pende D., Rivera P., Marcenaro S., Chang C.C., Biassoni R., Conte R., et al. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res 2002, 62:6178-6186.
40. Menier C., Riteau B., Carosella E.D., Rouas-Freiss N. MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal. Int J Cancer 2002, 100:63-70.
41. Trowsdale J., Barten R., Haude A., Stewart C.A., Beck S., Wilson M.J. The genomic context of natural killer receptor extended gene families. Immunol Rev 2001, 181:20-38.
42. Colonna M., Borsellino G., Falco M., Ferrara G.B., Strominger J.L. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci USA 1993, 90:12000-12004.
43. Moretta A., Vitale M., Bottino C., Orengo A.M., Morelli L., Augugliaro R., et al. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med 1993, 178:597-604.
44. Gumperz J.E., Litwin V., Phillips J.H., Lanier L.L., Parham P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 1995, 181:1133-1144.
45. Döhring C., Scheidegger D., Samaridis J., Cella M., Colonna M. A human killer inhibitory receptor specific for HLA-A1,2. J Immunol 1996, 156:3098-3101.
46. Pende D., Biassoni R., Cantoni C., Verdiani S., Falco M., di Donato C., et al. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kDa disulphide-linked dimer. J Exp Med 1996, 184:505-518.
47. Griffiths G.M. Cell mediated cytotoxicity. Immunology 2006, 203-214. Elsevier, Oxford. 7th ed. D. Male, J. Brostoff, D.B. Roth, I. Roitt (Eds.).
48. Ito T., Ito N., Saatoff M., Hashizume H., Fukamizu H., Nickoloff B.J., et al. Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. J Invest Dermatol 2008, 128:1196-1206.
49. Deng L., Mariuzza R.A. Structural basis for recognition of MHC and MHC-like ligands by natural killer cell receptors. Semin Immunol 2006, 18:159-166.
50. Groh V., Steinle A., Bauer S., Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 1998, 279:1737-1740.
51. Groh V., Rhinehart R., Secrist H., Bauer S., Grabstein K.H., Spies T. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci USA 1999, 96:6879-6884.
52. Kaufman G., d'Ovidio R., Kaldawy A., Assy B., Ullmann Y., Etzioni A., et al. An unexpected twist in alopecia areata pathogenesis: are NK cells protective and CD49b+ T cells pathogenic?. Exp Dermatol 2010, 19:e347-e349.
53. Meyer K.C., Bodó E., Brzoska T., Abels C., Paus R. Immunomodulatory effects of the alpha-melanocyte-stimulating hormone-related tripeptide K(D)PT on human scalp hair follicles under proinflammatory conditions. Br J Dermatol 2009, 161:1400-1403.
54. Gorczynski R.M., Chen Z., Shivagnahnam S., Taseva A., Wong K., Yu K., et al. Potent immunosuppression by a bivalent molecule binding to CD200R and TGF-betaR. Transplantation 2010, 90:150-159.
55. Ohyama M., Terunuma A., Tock C.L., Radonovich M.F., Pise-Masison C.A., Hopping S.B., et al. Characterization and isolation of stem cell-enriched human hair follicle bulge cells. J Clin Invest 2006, 116:249-260.
56. Slominski A., Wortsman J., Luger T., Paus R., Solomon S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 2000, 80:979-1020.
57. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000, 23:477-501.
58. Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J Affect Disord 2001, 62:77-91.
59. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 1996, 17:187-205.
60. Holsboer F., Ising M. Central CRH system in depression and anxiety-evidence from clinical studies with CRH1 receptor antagonists. Eur J Pharmacol 2008, 583:350-357.
61. Steinberg R., Alonso R., Griebel G., Bert L., Jung M., Oury-Donat F., et al. Selective blockade of neurokinin-2 receptors produces antidepressant-like effects associated with reduced corticotropin-releasing factor function. J Pharmacol Exp Ther 2001, 299:449-458.
62. Arborelius L., Owens M.J., Plotsky P.M., Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 1999, 160:1-12.
63. Roloff B., Fechner K., Slominski A., Furkert J., Botchkarev V.A., Bulfone-Paus S., et al. Hair cycle-dependent expression of corticotropin releasing factor (CRF) and CRF receptors in murine skin. FASEB J 1998, 12:287-297.
64. Arck P.C., Handjiski B., Peters E.M., Peter A.S., Hagen E., Fischer A., et al. Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways. Am J Pathol 2003, 162:803-814.
65. Maurer M., Fischer E., Handjiski B., von Stebut E., Algermissen B., Bavandi A., et al. Activated skin mast cells are involved in murine hair follicle regression (catagen). Lab Invest 1997, 77:319-332.
66. Ito N., Sugawara K., Bodó E., Takigawa M., van Beek N., Ito T., et al. Corticotropin-releasing hormone stimulates the in situ generation of mast cells from precursors in the human hair follicle mesenchyme. J Invest Dermatol 2010, 130:995-1004.
67. Kumamoto T., Shalhevet D., Matsue H., Mummert M.E., Ward B.R., Jester J.V., et al. Hair follicles serve as local reservoirs of skin mast cell precursors. Blood 2003, 102:1654-1660.
68. Brauner G.J., Goodheart H.P. Dermatologic care behind bars. J Am Acad Dermatol 1988, 18:1066-1073.
69. Muller S.A., Winkelmann R.K. Alopecia areata. An evaluation of 736 patients. Arch Dermatol 1963, 88:290-297.
70. Chrousos G.P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995, 332:1351-1362.
71. Garcia-Hernandez M.J., Ruiz-Doblado S., Rodriguez-Pichardo A., Camacho F. Alopecia areata, stress and psychiatric disorders: a review. J Dermatol 1999, 26:625-632.
72. Gulec A.T., Tanriverdi N., Duru C., Saray Y., Akcali C. The role of psychological factors in alopecia areata and the impact of the disease on the quality of life. Int J Dermatol 2004, 43:352-356.
73. Kakourou T., Karachristou K., Chrousos G. A case series of alopecia areata in children: impact of personal and family history of stress and autoimmunity. J Eur Acad Dermatol Venereol 2007, 21:356-359.
74. Inui S., Nakajima T., Toda N., Itami S. Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: retrospective analysis of 121 cases. J Dermatol 2009, 36:323-327.
75. Inui S., Nakajima T., Itami S. Two cases of alopecia areata responsive to fexofenadine. J Dermatol 2007, 34:852-854.
76. Ohyama M., Shimizu A., Tanaka K., Amagai M. Experimental evaluation of ebastine, a second-generation anti-histamine, as a supportive medication for alopecia areata. J Dermatol Sci 2010, 58:154-157.
77. Katsarou-Katsari A., Singh L.K., Theoharides T.C. Alopecia areata and affected skin CRH receptor upregulation induced by acute emotional stress. Dermatology 2001, 203:157-161.
78. Kim H.S., Cho D.H., Kim H.J., Lee J.Y., Cho B.K., Park H.J. Immunoreactivity of corticotropin-releasing hormone, adrenocorticotropic hormone and alpha-melanocyte-stimulating hormone in alopecia areata. Exp Dermatol 2006, 15:515-522.
79. Jessop J.J., Gale K., Bayer B.M. Enhancement of rat lymphocyte proliferation after prolonged exposure to stress. J Neuroimmunol 1987, 16:261-271.
80. Shanks N., Harbuz M.S., Jessop D.S., Perks P., Moore P.M., Lightman S.L. Inflammatory disease as chronic stress. Ann N Y Acad Sci 1998, 840:599-607.
81. Elenkov I.J., Chrousos G.P. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol Metab 1999, 10:359-368.
82. Elenkov I.J., Chrousos G.P. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 2002, 966:290-303.
83. Harbuz M.S., Richards L.J., Chover-Gonzalez A.J., Marti-Sistac O., Jessop D.S. Stress in autoimmune disease models. Ann N Y Acad Sci 2006, 1069:51-61.
84. Zhang X., Yu M., Yu W., Weinberg J., Shapiro L., McElwee K.J. Development of alopecia areata is associated with higher central and peripheral hypothalamic-pituitary-adrenal tone in the skin graft induced C3H/HeJ mouse model. J Invest Dermatol 2009, 129:1527-1538.
85. Ito T., Ito N., Bettermann A., Tokura Y., Takigawa M., Paus R. Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol 2004, 164:623-634.